Efficacy and Safety of the Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir Regimen for Chronic Hepatitis C in Hemodialysis Patients

Efficacy and Safety of the Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir Regimen for Chronic Hepatitis C in Hemodialysis Patients

Introduction: A higher percentage of sustained virologic response (SVR) has been reported with the introduction of direct-acting antivirals (DAAs) to the treatment of hepatitis C in recent years. However, there are still relatively limited data on the effectiveness and safety of the use of DAAs in h...

Full description

Bibliographic Details
Main Authors:	Güven Gürkan TOSUN, Fidan SULTANOVA, Nihan AK, Kenan HIZEL
Format:	Article
Language:	Turkish
Published:	Galenos Yayinevi 2019-12-01
Series:	Mediterranean Journal of Infection, Microbes and Antimicrobials
Subjects:	hepatitis c virus chronic renal failure thrombocytopenia adverse effect chronic kidney insufficiency
Online Access:	http://mjima.org/text.php?&id=171

Similar Items

Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir With or Without Ribavirin in Patients With Kidney Disease
by: David E. Bernstein, et al.
Published: (2019-02-01)

Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir and With or Without Ribavirin for Adolescents With HCV Genotype 1 or 4
by: Daniel H. Leung, et al.
Published: (2018-11-01)

Effectiveness of dasabuvir/ombitasvir/paritaprevir/ritonavir for hepatitis C virus in clinical practice: A population-based observational study.
by: Maya Leventer-Roberts, et al.
Published: (2017-01-01)

Ombitasvir/paritaprevir/ritonavir+dasabuvir and ribavirin associated drug-induced liver injury and syndrome of inappropriate secretion of anti-diuretic hormone: A case report
by: Rahul Kumar, et al.
Published: (2019-09-01)

The efficacy and safety of ombitasvir/paritaprevir/ritonavir plus ribavirin in hepatitis C virus-infected patients with end-stage renal disease on regular hemodialysis
by: Muhammad M A. Ghaffar, et al.
Published: (2021-01-01)

Study the response of Qurevo (ombitasvir, paritaprevir, and ritonavir) in end-stage renal disease patients with hepatitis C virus
by: Howayda Abd Elhameed Elshinnawy, et al.
Published: (2022-06-01)

Clinico-laboratory and immunological characteristics of patients with compensated cirrhosis of the liver in the outcome of chronic hepatitis C on the background of treatment with a direct antiviral drug paritrapeprir/ritonavir/ombitasvir/ dasabuvir
by: L. L. Popova, et al.
Published: (2018-12-01)

Sleep quality in people with chronic pain undergoing hemodialysis
by: Erika Veríssimo Dias Sousa, et al.
Published: (2023-11-01)

Assessment of the Impact of Fatigue on the Degree of Dependance in Hemodialysis Patients
by: Ana Elizabeth Figueiredo, et al.
Published: (2022-11-01)

Hemochromatosis (HFE) gene mutations in Brazilian chronic hemodialysis patients
by: F.V. Perícole, et al.
Published: (2005-09-01)

Are PTH levels related to oxidative stress and inflammation in chronic kidney disease patients on hemodialysis?
by: Marcel Jaqueto, et al.

Serum zinc values, ankle brachial index and mortality in hemodialysis patients
by: Knehtl Maša, et al.
Published: (2022-11-01)

Awareness of stroke among patients with chronic kidney disease on hemodialysis: a cross-sectional study
by: Orlando Vieira Gomes, et al.
Published: (2023-07-01)

HEPATITIS C TREATMENT OF RENAL TRANSPLANT AND CHRONIC KIDNEY DISEASE PATIENTS: EFFICACY AND SAFETY OF DIRECT-ACTING ANTIVIRAL REGIMENS CONTAINING SOFOSBUVIR
by: Fernanda Bellini Lunardi MICHELS, et al.
Published: (2020-02-01)

Survival in hemodialysis in Brazil according to the source of payment for the treatment: Public Healthcare System (SUS) versus private insurance
by: Ana Beatriz Lesqueves Barra, et al.
Published: (2023-01-01)

Sociodemographic and clinic factors associated with body mass index in patients with chronic kidney disease on hemodialysis
by: Ádria Juliane Lopes Melo Paiva, et al.
Published: (2022-11-01)

Prognostic impact of KIHON checklist score in elderly patients with hemodialysis initiation
by: Hayato Fujioka, et al.
Published: (2024-01-01)

Predictors of arteriovenous fistula maturation in hemodialysis patients: a prospective cohort from an ambulatory surgical center in Joinville, Brazil
by: Claudete Gasparin, et al.
Published: (2022-12-01)

Early Changes of Kidney Function Are a Tell for Heart Disease Risk
by: Sheldon W. Tobe
Published: (2022-11-01)

Epidemiological clinical characterization of patients with advanced chronic kidney disease
by: Lexis Caridad Ramírez Felipe, et al.
Published: (2016-07-01)

Effectiveness and Reliability of Splenectomy in Chronic Immune Thrombocytopenia
by: Rıdvan Ali, et al.
Published: (2020-07-01)

Secondary hyperparathyroidism due to multiple parathyroid carcinomas in a patient with chronic hemodialysis: a case report
by: Soree Ryang, et al.
Published: (2022-09-01)

Pain in Hemodialysis Patients: Prevalence, Intensity, Location, and Functional Interference in Daily Activities
by: Patrícia Roberta dos Santos, et al.
Published: (2021-10-01)

Cultural adaptation of The End-Stage Renal Disease Adherence Questionnaire for hemodialysis patients
by: Silvia Maria de Sá Basilio Lins, et al.

An Overview of Clinical Examinations in the Evaluation and Assessment of Arterial and Venous Insufficiency Wounds
by: Szu-Han Wang, et al.
Published: (2023-07-01)

High volume online hemodiafiltration: a global perspective and the Brazilian experience
by: Maria Eugenia Fernandes Canziani, et al.
Published: (2023-12-01)

Predictor Factors for Chronicity in Immune Thrombocytopenic Purpura in Children
by: Vasile Eduard Rosu, et al.
Published: (2023-05-01)

Dietary Acid Load and Relationship with Albuminuria and Glomerular Filtration Rate in Individuals with Chronic Kidney Disease at Predialysis State
by: Luísa Silva, et al.
Published: (2021-12-01)

Characteristic of the hemostasis indices in chronic venous insufficiency in stage of decompensation
by: V. І. Rusyn, et al.
Published: (2018-07-01)

TORASEMIDE SAFETY IN COMPLEX THERAPY OF CHRONIC CARDIAC INSUFFICIENCY: RESULTS OF RANDOMIZED CROSS STUDY
by: E. E. AVERIN
Published: (2016-12-01)

Aetiology of chronic kidney disease in rural patients
by: Sunil Dattu M, et al.
Published: (2016-10-01)

Evaluation of chronic inflammation in the aetiology of venous insufficiency by investigating cytomegalovirus DNA
by: Metin O. Beyaz, et al.
Published: (2019-05-01)

Anesthetic management for cesarean section in chronic renal failure
by: Hemlata Kapoor, et al.
Published: (2014-01-01)

Initially Reduced Linezolid Dosing Regimen to Prevent Thrombocytopenia in Hemodialysis Patients
by: Hitoshi Kawasuji, et al.
Published: (2021-04-01)

Danazol one Month Treatment of Thrombocytopenia in Chronic Hepatitis C
by: Hosam Dawod, et al.
Published: (2016-03-01)

Thrombocytopenia as a Bleeding Risk Factor in Atrial Fibrillation and Coronary Artery Disease: Insights From the AFIRE Study
by: Raisuke Iijima, et al.
Published: (2023-10-01)

Kidney disease and hemodialysis: identification of blood biomarkers to detect heart failure and kidney failure
by: Barbara Letícia Dudel Mayer, et al.
Published: (2020-08-01)

Knowledge: disease process in patients undergoing hemodialysis
by: Jeysse Karla de Araújo Ferreira, et al.
Published: (2018-06-01)

Association between prevalence and severity of chronic kidney disease and employment status: a nationwide study in Korea
by: Seoyeong Choi, et al.
Published: (2024-01-01)

Efficacy and Safety of Sugammadex for the Reversal of Rocuronium-Induced Neuromuscular Blockade in Patients with End-Stage Renal Disease: A Systematic Review and Meta-Analysis
by: Young-Sung Kim, et al.
Published: (2021-11-01)